DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Neurocrine Biosciences, Inc. (NBIX)
« Back to company indexNBIX Chatter Timeline
Stock Ticker for NBIX
Most Active Tweeters for NBIX
| User | Tweets |
|---|---|
| @whatsonthorold2 | 14 |
| @thefinreviewer | 10 |
| @reurope_stock | 10 |
| @mmahotstuff1 | 9 |
| @bulletin_en | 9 |
Recent Tweets for NBIX
 |
@ConsumerFeed Neurocrine Biosciences $NBIX Downgraded by ValuEngine to Hold https://t.co/6P58xQFZS8 April 19th 2019, 2:04pm |
 |
@AmericanBanking Research Analysts’ Weekly Ratings Changes for Neurocrine Biosciences $NBIX https://t.co/06i6QkuS9D #stocks April 19th 2019, 9:04am |
 |
@ThisLincolnian Research Analysts’ Weekly Ratings Changes for Neurocrine Biosciences $NBIX https://t.co/5oOgIWF4vM April 19th 2019, 8:04am |
 |
@TheMarketsDaily Neurocrine Biosciences $NBIX Downgraded by Zacks Investment Research to Hold https://t.co/HKZb2ieJzl April 19th 2019, 4:04am |
 |
@macondailynews Neurocrine Biosciences $NBIX Rating Lowered to Hold at Zacks Investment Research https://t.co/k0ze5f73A0 April 19th 2019, 4:04am |
 |
@thefinreviewer Comparison of EyeGate Pharmaceuticals Inc. $NBIX https://t.co/yIzJA5pSWB April 19th 2019, 1:04am |
|
@ThisLincolnian Neurocrine Biosciences $NBIX Lowered to “Hold” at Zacks Investment Research https://t.co/A31eENyJw1 April 18th 2019, 11:04am |
 |
@WeekHerald Neurocrine Biosciences $NBIX Lowered to “Hold” at Zacks Investment Research https://t.co/egiFW9ltWh April 18th 2019, 11:04am |
 |
@dailypoliticaln Neurocrine Biosciences $NBIX Downgraded by ValuEngine https://t.co/YCGDsO9OHy April 18th 2019, 9:04am |
 |
@ZolmaxNews Neurocrine Biosciences $NBIX Downgraded by ValuEngine https://t.co/BwulhI2foJ April 18th 2019, 9:04am |
 |
@fda_tracker $NBIX Phase 2 trial w/est Apr completion date NCT03525886: https://t.co/EiMjZSPyRi Trial Tracker: https://t.co/aR7q5oJwjn April 18th 2019, 9:04am |
|
@ConsumerFeed Head to Head Survey: Neurocrine Biosciences $NBIX & Iovance Biotherapeutics $IOVA https://t.co/joz4W4sNBO April 18th 2019, 12:04am |
|
@AmericanBanking Head to Head Survey: Neurocrine Biosciences $NBIX & Iovance Biotherapeutics $IOVA https://t.co/Jd0OoxbsOw #stocks April 18th 2019, 12:04am |
|
@ThisLincolnian Neurocrine Biosciences, Inc. $NBIX Receives Average Rating of “Buy” from Analysts https://t.co/3q7CZsGH96 April 17th 2019, 11:04pm |
 |
@UlmHi ImmuCell Corporation $NBIX https://t.co/3rEo5VEXes April 17th 2019, 8:04pm |
|
@UlmHi Contrasting of Dermira Inc. $NBIX https://t.co/lxFYBfdzXb April 17th 2019, 5:04pm |
 |
@Allstocknews $NBIX ALERT: New Neurocrine Biosciences SEC Filing From our Stock News Alerts App April 17th 2019, 4:04pm |
 |
@Stock_News_Now $NBIX: New SEC Filing for NBIX: Form DEF 14A (No. 0001193125-19-109100): https://t.co/zCwwffWkdR April 17th 2019, 4:04pm |
 |
@BlogYomi Neurocrine Bioscienc $NBIX Shareholder Botty Investors Raised Stake; Lyrical Asset Management LP Boosted Whirlpool… https://t.co/zs5R95WGSN April 17th 2019, 12:04pm |
 |
@bulletin_en Neurocrine Biosciences INC $NBIX Shares Declined While Bb Biotech Ag Increased Its Stake by $13.14 Million https://t.co/m0YQ0TbqB8 April 17th 2019, 10:04am |
|
@BlogYomi As Neurocrine Biosciences $NBIX Share Value Declined, Healthcor Management LP Has Increased Holding by $37.59 Milli… https://t.co/priUaFf74l April 17th 2019, 9:04am |
 |
@reurope_stock Neurocrine Biosciences INC $NBIX Holder Bb Biotech Ag Has Boosted Its Position by $13.14 Million as Stock Value De… https://t.co/gVG5I5VJ0C April 17th 2019, 8:04am |
|
@UlmHi Botty Investors Raised Neurocrine Bioscienc $NBIX Holding; Safeguard Scientifics $SFE Shareholder Yakira Capital Ma… https://t.co/iQsNxtt0vv April 17th 2019, 8:04am |
|
@ZolmaxNews Neurocrine Biosciences $NBIX Stock Rating Lowered by Zacks Investment Research https://t.co/I0fnG2BvXg April 17th 2019, 5:04am |
|
@bulletin_en Holder Birchview Capital LP Raised Neurocrine Biosciences $NBIX Holding; Concourse Capital Management Has Trimmed I… https://t.co/EcsksMKFGg April 17th 2019, 5:04am |
 |
@raiankanpai @lblegend33 $nbix often named as a b/o candidate. Not one offer to this day. :( April 16th 2019, 9:04pm |
 |
@monroewarriors5 @lblegend33 $NBIX looks a good candidate for buyout. April 16th 2019, 5:04pm |
 |
@whatsonthorold2 EPS for Neurocrine Biosciences, Inc. $NBIX Expected At $-0.92 https://t.co/BSbx7mJxZz April 16th 2019, 3:04pm |
|
@whatsonthorold2 Neurocrine Biosciences Inc $NBIX's Stock Is Buy After Less Market Selling https://t.co/9wiltggySs April 16th 2019, 12:04pm |
 |
@bibeypost_stock Neurocrine Biosciences Inc $NBIX Short Interest Decreased By 6.02% https://t.co/nvTAqJO4ZZ April 16th 2019, 12:04pm |
 |
@ChartMill $NBIX shows a strong growth in Revenue. Over the last 5 years it has been growing by 174.05% yearly.… https://t.co/ui3ucAF5ka April 16th 2019, 11:04am |
|
@bibeypost_stock Neurocrine Biosciences Inc $NBIX: Negative Stock Sentiment https://t.co/uOdxg05KSu April 16th 2019, 8:04am |
|
@BlogYomi Comparing of Cambrex Corporation $NBIX https://t.co/GJ8zjug6J7 April 16th 2019, 8:04am |
|
@BlogYomi As Neurocrine Biosciences $NBIX Valuation Declined, Holder Baker Bros Advisors LP Cut Position; Firstenergy $FE Ho… https://t.co/nS2Versb6M April 16th 2019, 7:04am |
 |
@mmahotstuff1 Analysts take a look at Neurocrine Biosciences, Inc. $NBIX having this to say. https://t.co/HgnuHw17LT April 16th 2019, 6:04am |
|
@whatsonthorold2 This is what analysts have to say about Neurocrine Biosciences, Inc. $NBIX after last week. https://t.co/AYZNMCE2D1 April 16th 2019, 6:04am |
|
@bibeypost_stock Analysts take a look at Neurocrine Biosciences, Inc. $NBIX having this to say. https://t.co/xEd7jBbAb5 April 16th 2019, 6:04am |
 |
@TranscriptDaily Neurocrine Biosciences $NBIX Downgraded by ValuEngine to Hold https://t.co/N7MeXlXIJq April 16th 2019, 3:04am |
 |
@dispatchtribune Neurocrine Biosciences $NBIX Downgraded by ValuEngine to Hold https://t.co/AqDbNpb3UM April 16th 2019, 3:04am |
|
@macondailynews Neurocrine Biosciences $NBIX Downgraded by ValuEngine to Hold https://t.co/UC32rvZkMv April 15th 2019, 11:04pm |
 |
@dakotafinancial Neurocrine Biosciences $NBIX Downgraded by ValuEngine to Hold https://t.co/469MUf7781 April 15th 2019, 11:04pm |
|
@TranscriptDaily Neurocrine Biosciences, Inc. $NBIX Given Average Rating of “Buy” by Brokerages https://t.co/UH40YJTrbM April 15th 2019, 8:04pm |
|
@thefinreviewer Dafna Capital Management Position In Neurocrine Biosciences $NBIX Was Upped; Cubesmart $CUBE Share Price Rose While… https://t.co/qCmxvHNeyV April 15th 2019, 2:04pm |
|
@mmahotstuff1 Analysts See $-0.92 EPS for Neurocrine Biosciences, Inc. $NBIX https://t.co/Cig2t4dJnx April 15th 2019, 2:04pm |
|
@whatsonthorold2 Analysts See $-0.92 EPS for Neurocrine Biosciences, Inc. $NBIX https://t.co/xAirukgCpf April 15th 2019, 2:04pm |
|
@reurope_stock Neurocrine Biosciences, Inc. $NBIX EPS Estimated At $-0.92 https://t.co/gI70UP5D2t April 15th 2019, 2:04pm |
|
@bulletin_en Neurocrine Biosciences $NBIX Share Price Declined While Rock Springs Capital Management LP Boosted Stake by $10.20… https://t.co/9Req2Gs8YS April 15th 2019, 1:04pm |
 |
@Figure9Capital RT @UlmHi: Neurocrine Biosciences $NBIX Holding Maintained by Comerica Bank; Pathstone Family Office Has Lifted Holding in Apple $AAPL as M… April 15th 2019, 12:04pm |
|
@UlmHi Neurocrine Biosciences $NBIX Holding Maintained by Comerica Bank; Pathstone Family Office Has Lifted Holding in App… https://t.co/OIWsEKsZpX April 15th 2019, 12:04pm |
|
@TranscriptDaily Neurocrine Biosciences $NBIX Now Covered by Analysts at Evercore ISI https://t.co/lJSOSqZXQi April 15th 2019, 8:04am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.